首页> 美国卫生研究院文献>Molecular Oncology >uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM‐CSF but dependent on TIMP‐1 in endothelial and glioblastoma cells
【2h】

uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM‐CSF but dependent on TIMP‐1 in endothelial and glioblastoma cells

机译:uPA和uPAR shRNA通过增强SVEGFR1的分泌来抑制血管生成而SVEGFR1的分泌独立于GM-CSF但依赖于内皮细胞和胶质母细胞瘤细胞中的TIMP-1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The uPA/uPAR system is known to play a critical role in angiogenesis of glioblastoma. Previously, we have shown that shRNA against uPA and uPAR attenuates angiogenesis by blocking nuclear translocation of angiogenin, inhibition of angiopoietin/Tie2 signaling, and regulating several other pro‐angiogenic, angiostatic and anti‐angiogenic molecules. Further analysis revealed that GM‐CSF, a pleiotropic cytokine, was significantly inhibited in U87MG and 4910 co‐cultures with endothelial cells transfected with shRNA against uPA and uPAR. The role of the uPA/uPAR system in this process is not completely understood. Analysis of tumor conditioned medium of U87MG, 4910 and HMECs transfected with shRNA against uPA or uPAR alone or in combination (pU2) revealed inhibition of GM‐CSF‐enhanced secretion of SVEGFR1 as shown by Western blotting and ELISA. Moreover, phosphorylation of JAK2 and STAT5, the downstream effectors of GM‐CSF signaling, was also inhibited in all three cell lines. Phosphorylation at Tyr 166 position of the GM‐CSFRβ subunit, the signal activating subunit of the GM‐CSF receptor, was inhibited in HMEC, U87MG and 4910 cells. Further analysis revealed that shRNA against uPA and/or uPAR increased secretion of TIMP‐1, which is known to enhance SVEGFR1 secretion in endothelial cells. Moreover, addition of purified uPA (with and without GM‐CSF) activated JAK2/STAT5 signaling in HMEC. Exogenous addition of SVEGFR1 to pU2 tumor conditioned medium enhanced inhibition of VEGF‐induced endothelial capillary tube formation as assessed by an in vitro angiogenesis assay. To determine the significance of these events in vivo, nude mice with pre‐established tumors treated with shRNA against uPA and/or uPAR showed decreased levels of GM‐CSF and increased levels of SVEGFR1 and TIMP‐1 when compared with controls. Enhanced secretion of SVEGFR1 by puPA, puPAR and pU2 in endothelial and GBM cells was mediated indirectly by MMP‐7 and augmented by ectodomain shedding of VEGFr1 by tyrosine phosphorylation at the 1213 position. Taken together, these results suggest that the uPA/uPAR system could prove beneficial as an indirect target for inhibition of angiogenesis in glioblastoma.
机译:已知uPA / uPAR系统在胶质母细胞瘤的血管生成中起关键作用。以前,我们已经证明针对uPA和uPAR的shRNA通过阻断血管生成素的核易位,抑制血管生成素/ Tie2信号传导并调节其他几种促血管生成,血管生成和抗血管生成分子来减弱血管生成。进一步的分析表明,在U87MG和4910共培养的u87MG和4910共培养的uPA和uPAR的内皮细胞中,GM-CSF被显着抑制了。 uPA / uPAR系统在此过程中的作用尚未完全了解。分别用uPA或uPAR或联合使用uPA或uPAR(pU2)转染shRNA的U87MG,4910和HMECs的肿瘤条件培养基进行分析显示,如Western blotting和ELISA所示,抑制了GM-CSF增强的SVEGFR1分泌。此外,在所有三个细胞系中,GM-CSF信号的下游效应子JAK2和STAT5的磷酸化也受到抑制。 HMEC,U87MG和4910细胞中GM-CSF受体的信号激活亚基GM-CSFRβ亚基的Tyr 166位的磷酸化受到抑制。进一步的分析表明,针对uPA和/或uPAR的shRNA增加了TIMP-1的分泌,已知该物质可增强内皮细胞中SVEGFR1的分泌。此外,在HMEC中添加纯化的uPA(有或没有GM-CSF)可激活JAK2 / STAT5信号传导。通过体外血管生成测定评估,在pU2肿瘤条件培养基中外加SVEGFR1可增强对VEGF诱导的内皮毛细管形成的抑制作用。为了确定这些事件在活体内的重要性,与对照组相比,已接受针对uPA和/或uPAR的shRNA预处理的具有预先建立的肿瘤的裸鼠显示GM-CSF水平降低,SVEGFR1和TIMP-1水平升高。 MMP-7间接介导了puPA,puPAR和pU2在内皮细胞和GBM细胞中增强SVEGFR1的分泌,并通过1213位酪氨酸磷酸化使VEGFr1胞外域脱落而增强。综上所述,这些结果表明,uPA / uPAR系统可以作为抑制胶质母细胞瘤血管生成的间接靶标而受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号